Loading clinical trials...

Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System

NCT07225478•Colgate Palmolive

View on ClinicalTrials.gov

Summary

The goal of this clinical study is to evaluate how well a new in-office whitening system works to whiten teeth compared to some other commercially available in-office whitening systems.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Signed Informed Consent Form
•Male and female subjects aged 18-70 years, inclusive;
•Good general health and good oral health based on the opinion of the study investigator;
•All maxillary natural anterior teeth (teeth #6 through #11) must be present;
•Availability for the duration of the study;
•Minimum average Vita Extended Bleachedguide 3D-Master shade score of 17 ≥ or darker.

Exclusion Criteria

•Presence of orthodontic appliances and/or any anterior tooth with a prosthetic crown, veneer, or deemed non-vital;
•Obvious signs of periodontal disease, rampant caries, or any condition that the dental examiner considers exclusionary from the study.
•Five or more carious lesions requiring immediate care.
•Concurrent participation in another oral clinical study.
•Self-reported pregnant and/or lactating women.
•History of allergies or sensitivity to tooth whitening products, hydrogen peroxide, personal care consumer products, or their ingredients;
•Restorations on the teeth to be scored which may interfere with scoring procedures.
•Have used professional whitening products within one (1) year and/or had dental prophylaxis (professional dental cleaning) within thirty (30) days prior to the start of the study.

Locations (1)

Consumer Research Consulting, LLC

Melbourne, Florida, United States

Key Dates

Start Date

October 31, 2025

Primary Completion Date

December 21, 2025

Completion Date

December 21, 2025

Last Updated

January 8, 2026

Enrollment

180

ACTUAL participants

Conditions

Health Adult Subjects

Interventions

Beaming White

DRUG

Philips Zoom Professional Whitening Treatment

COMBINATION_PRODUCT

Opalescence Boost PF

COMBINATION_PRODUCT

Fluoride Toothpaste

DRUG

Soft Manual Toothbrush

DEVICE

CP LED

DEVICE

Gingival Barrier

DEVICE

Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and Without Tennis Elbow (TE)

NCT07178288

Tennis ElbowHealth Adult Subjects+3 more

View study

COMPLETEDEARLY_PHASE1

Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort

NCT07336836

Health Adult SubjectsHealthy Participants

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System

Inclusion Criteria

Exclusion Criteria

Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and Without Tennis Elbow (TE)

Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort

Musical Stimulation Intensity and Postural Control (MUSIC-POST)